216 related articles for article (PubMed ID: 25096613)
1. Are blood-based protein biomarkers for Alzheimer's disease also involved in other brain disorders? A systematic review.
Chiam JT; Dobson RJ; Kiddle SJ; Sattlecker M
J Alzheimers Dis; 2015; 43(1):303-14. PubMed ID: 25096613
[TBL] [Abstract][Full Text] [Related]
2. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
3. Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study.
Kiddle SJ; Sattlecker M; Proitsi P; Simmons A; Westman E; Bazenet C; Nelson SK; Williams S; Hodges A; Johnston C; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Newhouse S; Lovestone S; Dobson RJ
J Alzheimers Dis; 2014; 38(3):515-31. PubMed ID: 24121966
[TBL] [Abstract][Full Text] [Related]
4. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
[TBL] [Abstract][Full Text] [Related]
5. Ultrasensitive detection of blood biomarkers of Alzheimer's and Parkinson's diseases: a systematic review.
Singh K; Cheung BM; Xu A
Biomark Med; 2021 Dec; 15(17):1693-1708. PubMed ID: 34743546
[No Abstract] [Full Text] [Related]
6. Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.
Kitamura Y; Usami R; Ichihara S; Kida H; Satoh M; Tomimoto H; Murata M; Oikawa S
Neurol Res; 2017 Mar; 39(3):231-238. PubMed ID: 28107809
[TBL] [Abstract][Full Text] [Related]
7. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - A pilot study from a tertiary center in Northern India.
Vishnu VY; Modi M; Garg VK; Mohanty M; Goyal MK; Lal V; Mittal BR; Prabhakar S
Asian J Psychiatr; 2017 Oct; 29():59-62. PubMed ID: 29061429
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
Goldknopf IL; Park HR; Sabbagh M
Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
[TBL] [Abstract][Full Text] [Related]
9. Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study.
Souchet B; Michaïl A; Heuillet M; Dupuy-Gayral A; Haudebourg E; Pech C; Berthemy AA; Autelitano F; Billoir B; Domoto-Reilly K; Fowler C; Grabowski T; Jayadev S; Masters CL; Braudeau J
J Prev Alzheimers Dis; 2024; 11(3):567-581. PubMed ID: 38706273
[TBL] [Abstract][Full Text] [Related]
10. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease.
Wang H; Dey KK; Chen PC; Li Y; Niu M; Cho JH; Wang X; Bai B; Jiao Y; Chepyala SR; Haroutunian V; Zhang B; Beach TG; Peng J
Mol Neurodegener; 2020 Jul; 15(1):43. PubMed ID: 32711556
[TBL] [Abstract][Full Text] [Related]
12. Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review.
Chaudhry A; Houlden H; Rizig M
J Neurol Sci; 2020 Aug; 415():116886. PubMed ID: 32428759
[TBL] [Abstract][Full Text] [Related]
13. Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy.
Chouliaras L; Thomas A; Malpetti M; Donaghy P; Kane J; Mak E; Savulich G; Prats-Sedano MA; Heslegrave AJ; Zetterberg H; Su L; Rowe JB; O'Brien JT
J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):651-658. PubMed ID: 35078917
[TBL] [Abstract][Full Text] [Related]
14. Identification of blood biomarkers for use in point of care diagnosis tool for Alzheimer's disease.
Jammeh E; Zhao P; Carroll C; Pearson S; Ifeachor E
Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():2415-2418. PubMed ID: 28268812
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging and analytical methods for studying the pathways from mild cognitive impairment to Alzheimer's disease: protocol for a rapid systematic review.
Ahmadzadeh M; Christie GJ; Cosco TD; Moreno S
Syst Rev; 2020 Apr; 9(1):71. PubMed ID: 32241302
[TBL] [Abstract][Full Text] [Related]
16. A Group of Long Non-coding RNAs in Blood Acts as a Specific Biomarker of Alzheimer's Disease.
Ren Z; Chu C; Pang Y; Cai H; Jia L
Mol Neurobiol; 2023 Feb; 60(2):566-575. PubMed ID: 36327022
[TBL] [Abstract][Full Text] [Related]
17. Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
Westwood S; Baird AL; Anand SN; Nevado-Holgado AJ; Kormilitzin A; Shi L; Hye A; Ashton NJ; Morgan AR; Bos I; Vos SJB; Baker S; Buckley NJ; Ten Kate M; Scheltens P; Teunissen CE; Vandenberghe R; Gabel S; Meersmans K; Engelborghs S; De Roeck EE; Sleegers K; Frisoni GB; Blin O; Richardson JC; Bordet R; Molinuevo JL; Rami L; Wallin A; Kettunen P; Tsolaki M; Verhey F; Lléo A; Sala I; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Johannsen P; Freund-Levi Y; Frölich L; Dobricic V; Legido-Quigley C; Bertram L; Barkhof F; Zetterberg H; Morgan BP; Streffer J; Visser PJ; Lovestone S
J Alzheimers Dis; 2020; 74(1):213-225. PubMed ID: 31985466
[TBL] [Abstract][Full Text] [Related]
18. Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.
Aluise CD; Sowell RA; Butterfield DA
Biochim Biophys Acta; 2008 Oct; 1782(10):549-58. PubMed ID: 18760351
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology.
Sattlecker M; Kiddle SJ; Newhouse S; Proitsi P; Nelson S; Williams S; Johnston C; Killick R; Simmons A; Westman E; Hodges A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; ; Dobson RJ
Alzheimers Dement; 2014 Nov; 10(6):724-34. PubMed ID: 24768341
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
